Investigating the links between retinopathy, macular edema and visual acuity in patients with diabetes

References

• Klein R, Klein BE, Moss SE. The Wisconsin epidemiological study of diabetic retinopathy: a review. Diabetes Metab. Rev.5(7), 559–570 (1989).
   PubMed Web of Science ®Google Scholar
• National Society to Prevent Blindness. Vision Problems in the US: Facts and Figures. National Society to Prevent Blindness, NY, USA (1980).
   Google Scholar
• Younis N, Broadbent DM, Harding SP, Vora JR. Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme. Diabet. Med.19(12), 1014–1021 (2002).
   PubMed Web of Science ®Google Scholar
• Skrivarhaug T, Fosmark DS, Stene LC et al. Low cumulative incidence of proliferative retinopathy in childhood-onset Type 1 diabetes: a 24-year follow-up study. Diabetologia49(10), 2281–2290 (2006).
   PubMed Web of Science ®Google Scholar
• Nordwall M, Bojestig M, Arnqvist HJ, Ludvigsson J. Declining incidence of severe retinopathy and persisting decrease of nephropathy in an unselected population of Type 1 diabetes – the Linkoping Diabetes Complications Study. Diabetologia47(7), 1266–1272 (2004).
   PubMed Web of Science ®Google Scholar
• Hovind P, Tarnow L, Rossing K et al. Decreasing incidence of severe diabetic microangiopathy in Type 1 diabetes. Diabetes Care26(4), 1258–1264 (2003).
   PubMed Web of Science ®Google Scholar
• Henricsson M, Nystrom L, Blohme G et al. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS). Diabetes Care26(2), 349–354 (2003).
   PubMed Web of Science ®Google Scholar
• Cikamatana L, Mitchell P, Rochtchina E, Foran S, Wang JJ. Five-year incidence and progression of diabetic retinopathy in a defined older population: the Blue Mountains Eye Study. Eye21(4), 465–471 (2007).
   PubMed Web of Science ®Google Scholar
• Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with Type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet361(9353), 195–200 (2003).
   PubMed Web of Science ®Google Scholar
• Stratton IM, Kohner EM, Aldington SJ et al. UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis. Diabetologia44(2), 156–163 (2001).
   PubMed Web of Science ®Google Scholar
• Bamashmus MA, Matlhaga B, Dutton GN. Causes of blindness and visual impairment in the West of Scotland. Eye18(3), 257–261 (2004).
   PubMed Web of Science ®Google Scholar
• Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health6, 58 (2006).
   PubMed Web of Science ®Google Scholar
• Kelliher C, Kenny D, O’Brien C. Trends in blind registration in the adult population of the Republic of Ireland 1996–2003. Br. J. Ophthalmol.90(3), 367–371 (2006).
   PubMed Web of Science ®Google Scholar
• Ways DK, Sheetz MJ. The role of protein kinase C in the development of the complications of diabetes. Vitam. Horm.60, 149–193 (2000).
   PubMed Web of Science ®Google Scholar
• West SK, Klein R, Rodriguez J et al. Diabetes and diabetic retinopathy in a Mexican–American population: Proyecto VER. Diabetes Care24(7), 1204–1209 (2001).
   PubMed Web of Science ®Google Scholar
• The DCCT Research Group. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial. Arch. Ophthalmol.113(1), 36–51. (1995).
   PubMed Web of Science ®Google Scholar
• Matthews DR, Stratton IM, Aldington SJ, Holman RR, Kohner EM. Risks of progression of retinopathy and vision loss related to tight blood pressure control in Type 2 diabetes mellitus: UKPDS 69. Arch. Ophthalmol.122(11), 1631–1640 (2004).
   PubMed Web of Science ®Google Scholar
• UKPDS Group. Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes: UKPDS 38. BMJ317, 703–713 (1998).
   PubMed Web of Science ®Google Scholar
• Estacio RO, Jeffers BW, Gifford N, Schrier RW. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and Type 2 diabetes. Diabetes Care23(Suppl. 2), B54–B64 (2000).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology102(1), 7–16 (1995).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in Type 1 diabetes. Ophthalmology105(10), 1801–1815 (1998).
   PubMed Web of Science ®Google Scholar
• Chew EY, Ferris FL, III, Csaky KG et al. The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study. Ophthalmology110(9), 1683–1689 (2003).
   PubMed Web of Science ®Google Scholar
• Chew EY, Klein ML, Ferris FL et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Arch. Ophthalmol.114(9), 1079–1084 (1996).
   PubMed Web of Science ®Google Scholar
• Broman AT, Munoz B, Rodriguez J et al. The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: proyecto VER. Invest. Ophthalmol. Vis. Sci.43(11), 3393–3398 (2002).
   PubMed Web of Science ®Google Scholar
• Swanson MW, McGwin G. Visual impairment and functional status from the 1995 National Health Interview Survey on Disability. Ophthalmic Epidemiol.11(3), 227–239 (2004).
   PubMed Web of Science ®Google Scholar
• Klein BE, Klein R, Lee KE, Cruickshanks KJ. Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study. Ophthalmology105(1), 160–164 (1998).
   PubMed Web of Science ®Google Scholar
• West SK, Munoz B, Rubin GS et al. Function and visual impairment in a population-based study of older adults. The SEE project. Salisbury Eye Evaluation. Invest. Ophthalmol. Vis. Sci.38(1), 72–82 (1997).
   PubMed Web of Science ®Google Scholar
• Dargent-Molina P, Favier F, Grandjean H et al. Fall-related factors and risk of hip fracture: the EPIDOS prospective study. Lancet348(9021), 145–149 (1996).
   PubMed Web of Science ®Google Scholar
• Felson DT, Anderson JJ, Hannan MT, Milton RC, Wilson PW, Kiel DP. Impaired vision and hip fracture. The Framingham Study. J. Am. Geriatr. Soc.37(6), 495–500 (1989).
   PubMed Web of Science ®Google Scholar
• Ivers RQ, Cumming RG, Mitchell P, Attebo K. Visual impairment and falls in older adults: the Blue Mountains Eye Study. J. Am. Geriatr. Soc.46(1), 58–64 (1998).
   PubMed Web of Science ®Google Scholar
• Ivers RQ, Norton R, Cumming RG, Butler M, Campbell AJ. Visual impairment and risk of hip fracture. Am. J. Epidemiol.152(7), 633–639 (2000).
   PubMed Web of Science ®Google Scholar
• Tsai SY, Cheng CY, Hsu WM, Su TP, Liu JH, Chou P. Association between visual impairment and depression in the elderly. J. Formos. Med. Assoc.102(2), 86–90 (2003).
   PubMed Web of Science ®Google Scholar
• Early Treatment Diabetic Retinopathy Study research group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Arch. Ophthalmol.103(12), 1796–1806 (1985).
   PubMed Web of Science ®Google Scholar
• Lopes de Faria JM, Jalkh AE, Trempe CL, McMeel JW. Diabetic macular edema: risk factors and concomitants. Acta Ophthalmol. Scand.77(2), 170–175 (1999).
   PubMedGoogle Scholar
• Klein R, Klein BE, Moss SE. Visual impairment in diabetes. Ophthalmology91(1), 1–9 (1984).
   PubMed Web of Science ®Google Scholar
• Malone JI, Morrison AD, Pavan PR, Cuthbertson DD. Prevalence and significance of retinopathy in subjects with Type 1 diabetes of less than 5 years’ duration screened for the diabetes control and complications trial. Diabetes Care24(3), 522–526 (2001).
   PubMed Web of Science ®Google Scholar
• Harris MI, Klein R, Cowie CC, Rowland M, Byrd-Holt DD. Is the risk of diabetic retinopathy greater in non-Hispanic blacks and Mexican–Americans than in non-Hispanic whites with Type 2 diabetes? A U.S. population study. Diabetes Care21(8), 1230–1235 (1998).
   PubMed Web of Science ®Google Scholar
• Chaturvedi N, Jarrett J, Shipley MJ, Fuller JH. Socioeconomic gradient in morbidity and mortality in people with diabetes: cohort study findings from the Whitehall Study and the WHO Multinational Study of Vascular Disease in Diabetes. BMJ316(7125), 100–105 (1998).
   PubMed Web of Science ®Google Scholar
• Chaturvedi N, Stephenson JM, Fuller JH. The relationship between socioeconomic status and diabetes control and complications in the EURODIAB IDDM Complications Study. Diabetes Care19(5), 423–430 (1996).
   PubMed Web of Science ®Google Scholar
• Connolly VM, Kesson CM. Socioeconomic status and clustering of cardiovascular disease risk factors in diabetic patients. Diabetes Care19(5), 419–422 (1996).
   PubMed Web of Science ®Google Scholar
• Harris MI. Racial and ethnic differences in health insurance coverage for adults with diabetes. Diabetes Care22(10), 1679–1682 (1999).
   PubMed Web of Science ®Google Scholar
• Lantz PM, House JS, Lepkowski JM, Williams DR, Mero RP, Chen J. Socioeconomic factors, health behaviors, and mortality: results from a nationally representative prospective study of US adults. JAMA279(21), 1703–1708 (1998).
   PubMed Web of Science ®Google Scholar
• Mayberry RM, Mili F, Ofili E. Racial and ethnic differences in access to medical care. Med. Care Res. Rev.57(Suppl. 1), 108–145 (2000).
   PubMed Web of Science ®Google Scholar
• Robbins JM, Vaccarino V, Zhang H, Kasl SV. Excess Type 2 diabetes in African–American women and men aged 40–74 and socioeconomic status: evidence from the Third National Health and Nutrition Examination Survey. J. Epidemiol. Community Health54(11), 839–845 (2000).
   PubMed Web of Science ®Google Scholar
• Schneider EC, Zaslavsky AM, Epstein AM. Racial disparities in the quality of care for enrollees in medicare managed care. JAMA287(10), 1288–1294 (2002).
   PubMed Web of Science ®Google Scholar
• Wagstaff A, van Doorslaer E. Income inequality and health: what does the literature tell us? Annu. Rev. Public Health21, 543–567 (2000).
   PubMed Web of Science ®Google Scholar
• Henricsson M, Heijl A. Visual fields at different stages of diabetic retinopathy. Acta Ophthalmol. (Copenh.)72(5), 560–569 (1994).
   Google Scholar
• Henricsson M, Sellman A, Tyrberg M, Groop L. Progression to proliferative retinopathy and macular oedema requiring treatment. Assessment of the alternative classification of the Wisconsin Study. Acta Ophthalmol. Scand.77(2), 218–223 (1999).
   PubMedGoogle Scholar
• Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema. Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS report no. 19. Arch. Ophthalmol.113(9), 1144–1155 (1995).
   PubMed Web of Science ®Google Scholar
• Fong DS, Sharza M, Chen W, Paschal JF, Ariyasu RG, Lee PP. Vision loss among diabetics in a group model Health Maintenance Organization (HMO). Am. J. Ophthalmol.133(2), 236–241 (2002).
   PubMed Web of Science ®Google Scholar
• Delcourt C, Villatte-Cathelineau B, Vauzelle-Kervroedan F, Cathelineau G, Papoz L; CODIAB-INSERM-ZENECA Pharma Study Group. Visual impairment in Type 2 diabetic patients. A multicentre study in France. Acta Ophthalmol. Scand.73(4), 293–298 (1995).
   PubMedGoogle Scholar
• Zander E, Herfurth S, Bohl B et al. Maculopathy in patients with diabetes mellitus Type 1 and Type 2: associations with risk factors. Br. J. Ophthalmol.84(8), 871–876 (2000).
   PubMed Web of Science ®Google Scholar
• Kohner EM, Aldington SJ, Stratton IM et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. Arch. Ophthalmol.116(3), 297–303 (1998).
   PubMedGoogle Scholar
• Stein JD, Brown MM, Brown GC, Hollands H, Sharma S. Quality of life with macular degeneration: perceptions of patients, clinicians, and community members. Br. J. Ophthalmol.87(1), 8–12 (2003).
   PubMed Web of Science ®Google Scholar
• Taylor HR, Pezzullo ML, Keeffe JE. The economic impact and cost of visual impairment in Australia. Br. J. Ophthalmol.90(3), 272–275 (2006).
   PubMed Web of Science ®Google Scholar
• Bachmann MO, Nelson SJ. Impact of diabetic retinopathy screening on a British district population: case detection and blindness prevention in an evidence-based model. J. Epidemiol. Community Health52(1), 45–52 (1998).
   PubMed Web of Science ®Google Scholar
• Legorreta AP, Hasan MM, Peters AL, Pelletier KR, Leung KM. An intervention for enhancing compliance with screening recommendations for diabetic retinopathy. A bicoastal experience. Diabetes Care20(4), 520–523 (1997).
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. Factors associated with having eye examinations in persons with diabetes. Arch. Fam Med.4(6), 529–534 (1995).
   PubMedGoogle Scholar
• Schoenfeld ER, Greene JM, Wu SY, Leske MC. Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology108(3), 563–571 (2001).
   PubMed Web of Science ®Google Scholar
• McCarty CA, Taylor KI, McKay R, Keeffe JE. Diabetic retinopathy: effects of national guidelines on the referral, examination and treatment practices of ophthalmologists and optometrists. Clin. Experiment. Ophthalmol.29(2), 52–58 (2001).
   PubMed Web of Science ®Google Scholar
• The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med.329(14), 977–986 (1993).
   PubMed Web of Science ®Google Scholar
• Buckley S, Jenkins L, Benjamin L. Field loss after pan retinal photocoagulation with diode and argon lasers. Doc. Ophthalmol.82(4), 317–322. (1992).
   PubMed Web of Science ®Google Scholar
• Buckley SA, Jenkins L, Benjamin L. Fields, DVLC and panretinal photocoagulation. Eye6(Pt 6), 623–625 (1992).
   PubMed Web of Science ®Google Scholar
• Canning C, Polkinghorne P, Ariffin A, Gregor Z. Panretinal laser photocoagulation for proliferative diabetic retinopathy: the effect of laser wavelength on macular function. Br. J. Ophthalmol.75(10), 608–610 (1991).
   PubMed Web of Science ®Google Scholar
• Friberg TR, Venkatesh S. Alteration of pulse configuration affects the pain response during diode laser photocoagulation. Lasers Surg. Med.16(4), 380–383. (1995).
   PubMed Web of Science ®Google Scholar
• Pahor D. Visual field loss after argon laser panretinal photocoagulation in diabetic retinopathy: full- versus mild-scatter coagulation. Int. Ophthalmol.22(5), 313–319 (1998).
   PubMed Web of Science ®Google Scholar
• Patel JI, Jenkins L, Benjamin L, Webber S. Dilated pupils and loss of accommodation following diode panretinal photocoagulation with sub-tenon local anaesthetic in four cases. Eye16(5), 628–632 (2002).
   PubMed Web of Science ®Google Scholar
• Eyetech Study Group. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina22(2), 143–152 (2002).
   PubMed Web of Science ®Google Scholar
• Girach A, Aiello LP, Vignati L et al. Effect of the oral PKC inhibitor ruboxistaurin on vision loss in patients with diabetic retinopathy: The PKC-DRS2 Study Results. Eur. J. Ophthalmol.16(3), 500 (2006).
   Google Scholar
• Martidis A, Duker JS, Greenberg PB et al. Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology109(5), 920–927 (2002).
   PubMed Web of Science ®Google Scholar
• Nauck M, Karakiulakis G, Perruchoud AP, Papakonstantinou E, Roth M. Corticosteroids inhibit the expression of the vascular endothelial growth factor gene in human vascular smooth muscle cells. Eur. J. Pharmacol.341(2–3), 309–315 (1998).
   PubMed Web of Science ®Google Scholar
• Haritoglou C, Kook D, Neubauer A et al. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema. Retina26(9), 999–1005 (2006).
   PubMed Web of Science ®Google Scholar
• Kook D, Wolf A, Kreutzer T et al. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema. Retina28(8), 1053–1060 (2008).
   PubMed Web of Science ®Google Scholar
• Williams R, Airey M, Baxter H, Forrester J, Kennedy-Martin T, Girach A. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye18(10), 963–983 (2004).
   PubMed Web of Science ®Google Scholar
• King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care21(9), 1414–1431 (1998).
   PubMed Web of Science ®Google Scholar
• Cowie CC, Rust KF, Byrd-Holt DD et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999–2002. Diabetes Care29(6), 1263–1268 (2006).
   PubMed Web of Science ®Google Scholar
• Rosenberg EA, Sperazza LC. The visually impaired patient. Am. Fam. Physician77(10), 1431–1436 (2008).
   PubMed Web of Science ®Google Scholar
• Kristinsson JK, Hauksdottir H, Stefansson E, Jonasson F, Gislason I. Active prevention in diabetic eye disease. A 4-year follow-up. Acta Ophthalmol. Scand.75(3), 249–254 (1997).
   PubMedGoogle Scholar
• Aiello LP, Gardner TW, King GL et al. Diabetic retinopathy. Diabetes Care21(1), 143–156 (1998).
   PubMed Web of Science ®Google Scholar
• Backlund LB, Algvere PV, Rosenqvist U. New blindness in diabetes reduced by more than one-third in Stockholm County. Diabet. Med.14(9), 732–740 (1997).
   PubMed Web of Science ®Google Scholar
• Stefansson E, Bek T, Porta M, Larsen N, Kristinsson JK, Agardh E. Screening and prevention of diabetic blindness. Acta Ophthalmol. Scand.78(4), 374–385 (2000).
   PubMedGoogle Scholar
• Zoega GM, Gunnarsdottir T, Bjornsdottir S, Hreietharsson AB, Viggosson G, Stefansson E. Screening compliance and visual outcome in diabetes. Acta Ophthalmol. Scand.83(6), 687–690 (2005).
   PubMedGoogle Scholar
• Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann. Intern. Med.124(1 Pt 2), 164–169 (1996).
   PubMed Web of Science ®Google Scholar
• Vitale S, Maguire MG, Murphy RP et al. Clinically significant macular edema in Type I diabetes. Incidence and risk factors. Ophthalmology102(8), 1170–1176 (1995).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch. Ophthalmol.107(2), 237–243 (1989).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch. Ophthalmol.107(2), 244–249 (1989).
   PubMed Web of Science ®Google Scholar
• Benson WH, Farber ME. Diabetic retinopathy in a rural diabetic population. Prevalence and risk. WV Med. J.85(4), 141–143 (1989).
   Web of Science ®Google Scholar
• Berinstein DM, Stahn RM, Welty TK, Leonardson GR, Herlihy JJ. The prevalence of diabetic retinopathy and associated risk factors among Sioux Indians. Diabetes Care20(5), 757–759 (1997).
   PubMed Web of Science ®Google Scholar
• Hamman RF, Mayer EJ, Moo-Young GA, Hildebrandt W, Marshall JA, Baxter J. Prevalence and risk factors of diabetic retinopathy in non-Hispanic whites and Hispanics with NIDDM. San Luis Valley Diabetes Study. Diabetes38(10), 1231–1237 (1989).
   PubMed Web of Science ®Google Scholar
• Kempen JH, O’Colmain BJ, Leske MC et al. The prevalence of diabetic retinopathy among adults in the United States. Arch. Ophthalmol.122(4), 552–563 (2004).
   PubMed Web of Science ®Google Scholar
• Klein R, Davis MD, Moss SE, Klein BE, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. A comparison of retinopathy in younger and older onset diabetic persons. Adv. Exp. Med. Biol.189, 321–335 (1985).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE. A population-based study of diabetic retinopathy in insulin-using patients diagnosed before 30 years of age. Diabetes Care8(Suppl. 1), 71–76 (1985).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology91(12), 1464–1474 (1984).
   PubMed Web of Science ®Google Scholar
• Klein R, Klein BE, Moss SE, Linton KL. The Beaver Dam Eye Study. Retinopathy in adults with newly discovered and previously diagnosed diabetes mellitus. Ophthalmology99(1), 58–62 (1992).
   PubMed Web of Science ®Google Scholar
• Klein R, Palta M, Allen C, Shen G, Han DP, D’Alessio DJ. Incidence of retinopathy and associated risk factors from time of diagnosis of insulin-dependent diabetes. Arch. Ophthalmol.115(3), 351–356 (1997).
   PubMedGoogle Scholar
• Kostraba JN, Klein R, Dorman JS et al. The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. Am. J. Epidemiol.133(4), 381–391 (1991).
   PubMed Web of Science ®Google Scholar
• Leske MC, Wu SY, Hyman L et al. Diabetic retinopathy in a black population: the Barbados Eye Study. Ophthalmology106(10), 1893–1899 (1999).
   PubMed Web of Science ®Google Scholar
• Roy MS. Diabetic retinopathy in African–Americans with Type 1 diabetes: the New Jersey 725: I. Methodology, population, frequency of retinopathy, and visual impairment. Arch. Ophthalmol.118(1), 97–104 (2000).
   PubMedGoogle Scholar
• Roy MS, Klein R, O’Colmain BJ, Klein BE, Moss SE, Kempen JH. The prevalence of diabetic retinopathy among adult Type 1 diabetic persons in the United States. Arch. Ophthalmol.122(4), 546–551 (2004).
   PubMed Web of Science ®Google Scholar
• Varma R, Torres M, Pena F, Klein R, Azen SP. Prevalence of diabetic retinopathy in adult Latinos: the Los Angeles Latino eye study. Ophthalmology111(7), 1298–1306 (2004).
   PubMed Web of Science ®Google Scholar
• Broadbent DM, Scott JA, Vora JP, Harding SP. Prevalence of diabetic eye disease in an inner city population: the Liverpool Diabetic Eye Study. Eye13(Pt 2), 160–165 (1999).
   PubMed Web of Science ®Google Scholar
• Ling R, Ramsewak V, Taylor D, Jacob J. Longitudinal study of a cohort of people with diabetes screened by the Exeter Diabetic Retinopathy Screening Programme. Eye16(2), 140–145 (2002).
   PubMed Web of Science ®Google Scholar
• McLeod BK, Thompson JR, Rosenthal AR. The prevalence of retinopathy in the insulin-requiring diabetic patients of an English country town. Eye2(Pt 4), 424–430 (1988).
   PubMed Web of Science ®Google Scholar
• Morgan CL, Currie CJ, Stott NC, Smithers M, Butler CC, Peters JR. The prevalence of multiple diabetes-related complications. Diabet. Med.17(2), 146–151 (2000).
   PubMed Web of Science ®Google Scholar
• UKPDS Group. U.K. Prospective Diabetes Study 16. Overview of 6 years’ therapy of Type II diabetes: a progressive disease. Diabetes44, 1249–1258 (1995).
   PubMed Web of Science ®Google Scholar
• Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study. Diabetologia37(3), 278–285 (1994).
   PubMed Web of Science ®Google Scholar
• Agardh E, Torffvit O, Agardh CD. The prevalence of retinopathy and associated medical risk factors in Type I (insulin-dependent) diabetes mellitus. J. Intern. Med.226(1), 47–52 (1989).
   PubMed Web of Science ®Google Scholar
• Bognetti E, Calori G, Meschi F, Macellaro P, Bonfanti R, Chiumello G. Prevalence and correlations of early microvascular complications in young Type I diabetic patients: role of puberty. J. Pediatr. Endocrinol. Metab.10(6), 587–592 (1997).
   PubMed Web of Science ®Google Scholar
• Cahill M, Halley A, Codd M et al. Prevalence of diabetic retinopathy in patients with diabetes mellitus diagnosed after the age of 70 years. Br. J. Ophthalmol.81(3), 218–222 (1997).
   PubMed Web of Science ®Google Scholar
• Danielsen R, Jonasson F, Helgason T. Prevalence of retinopathy and proteinuria in Type 1 diabetics in Iceland. Acta Med. Scand.212(5), 277–280 (1982).
   PubMedGoogle Scholar
• De Pablos PL, Martinez J, Martinez MP, Doreste JA. Prevalence of micro- and macroalbuminuria in a Canarian population of Type 2 diabetic patients. Relationship with blood pressure, lipid profile, obesity and metabolic control. Diabetes Metab.24(4), 337–343 (1998).
   PubMed Web of Science ®Google Scholar
• Delcourt C, Vauzelle-Kervroedan F, Cathelineau G, Papoz L; CODIAB-INSERM-ZENECA Pharma Study Group. Low prevalence of long-term complications in non-insulin-dependent diabetes mellitus in France: a multicenter study. J. Diabetes Complicat.12(2), 88–95 (1998).
   PubMed Web of Science ®Google Scholar
• Ebeling P, Koivisto VA. Occurrence and interrelationships of complications in insulin-dependent diabetes in Finland. Acta Diabetol.34(1), 33–38 (1997).
   PubMed Web of Science ®Google Scholar
• Falkenberg M, Finnstrom K. Associations with retinopathy in Type 2 diabetes: a population-based study in a Swedish rural area. Diabet. Med.11(9), 843–849 (1994).
   PubMed Web of Science ®Google Scholar
• Fernandez-Vigo J, Sanchez MJ, Diaz RA, Barros J, Tome M, Bueno J. The prevalence of diabetic retinopathy in northwest Spain. An epidemiological study of diabetic retinopathy in Galicia. I. Acta Ophthalmol. (Copenh.)71(1), 22–26 (1993).
   Google Scholar
• Garancini P, Micossi P, Valsania P et al. Prevalence of retinopathy in diabetic subjects from out-patient clinics in Lombardy (Italy), and associated risk factors. A multicentre epidemiologic study. Diabetes Res. Clin. Pract.6(2), 129–138 (1989).
   PubMed Web of Science ®Google Scholar
• Hapnes R, Bergrem H. Diabetic eye complications in a medium sized municipality in southwest Norway. Acta Ophthalmol. Scand.74(5), 497–500 (1996).
   PubMedGoogle Scholar
• Haupt E, Benecke A, Haupt A, Herrmann R, Vogel H, Walter C. The KID Study VI: diabetic complications and associated diseases in younger Type 2 diabetics still performing a profession. Prevalence and correlation with duration of diabetic state, BMI and C-peptide. Exp. Clin. Endocrinol. Diabetes107(7), 435–441 (1999).
   PubMed Web of Science ®Google Scholar
• Henricsson M, Nilsson A, Groop L, Heijl A, Janzon L. Prevalence of diabetic retinopathy in relation to age at onset of the diabetes, treatment, duration and glycemic control. Acta Ophthalmol. Scand.74(6), 523–527 (1996).
   PubMedGoogle Scholar
• Hirvela H, Laatikainen L. Diabetic retinopathy in people aged 70 years or older. The Oulu Eye Study. Br. J. Ophthalmol.81(3), 214–217 (1997).
   PubMed Web of Science ®Google Scholar
• Hove MN, Kristensen JK, Lauritzen T, Bek T. The prevalence of retinopathy in an unselected population of Type 2 diabetes patients from Arhus County, Denmark. Acta Ophthalmol. Scand.82(4), 443–448 (2004).
   PubMedGoogle Scholar
• Jerneld B, Algvere P. Prevalence of retinopathy in diabetes treated with oral antihyperglycaemic agents. Acta Ophthalmol. (Copenh.)63(5), 535–540 (1985).
   Google Scholar
• Jerneld B, Algvere P. Relationship of duration and onset of diabetes to prevalence of diabetic retinopathy. Am. J. Ophthalmol.102(4), 431–437 (1986).
   PubMed Web of Science ®Google Scholar
• Kravchenko VI, Tronko ND, Pankiv VI, Venzilovich Y, Prudius FG. Prevalence of diabetes mellitus and its complications in the Ukraine. Diabetes Res. Clin. Pract.34(Suppl.), S73–S78 (1996).
   PubMed Web of Science ®Google Scholar
• Kuiv R, Tein P, Algvere PV, Backlund LB, Holm O. Photographic detection of retinopathy in insulin-treated diabetes. A population study in the city of Tartu, Estonia. Acta Ophthalmol. Scand.75(4), 447–456 (1997).
   PubMedGoogle Scholar
• Lopez IM, Diez A, Velilla S, Rueda A, Alvarez A, Pastor CJ. Prevalence of diabetic retinopathy and eye care in a rural area of Spain. Ophthalmic Epidemiol.9(3), 205–214 (2002).
   PubMed Web of Science ®Google Scholar
• Lundman B, Engstrom L. Diabetes and its complications in a Swedish county. Diabetes Res. Clin. Pract.39(2), 157–164 (1998).
   PubMed Web of Science ®Google Scholar
• Olsen BS, Johannesen J, Sjolie AK et al.; Danish Study Group of Diabetes in Childhood. Metabolic control and prevalence of microvascular complications in young Danish patients with Type 1 diabetes mellitus. Diabet. Med.16(1), 79–85 (1999).
   PubMed Web of Science ®Google Scholar
• Pinto-Figueiredo L, Moita J, Genro V et al. Diabetic retinopathy in a population of 1,302 insulin dependent diabetics (IDDM) diagnosed before 30 years of age. Int. Ophthalmol.16(6), 429–437 (1992).
   PubMed Web of Science ®Google Scholar
• Pisu E, Vitelli F, Coggi G et al. Univariate and multivariate analysis of associated factors of retinopathy in 894 Italian adult diabetics. Diabetes Metab.14(6), 700–705 (1988).
   Web of Science ®Google Scholar
• Reuterving CO, Kratholm J, Wachtmeister L. Ophthalmic health care in diabetes mellitus: a cross-sectional study in northern Sweden. Ophthalmic Epidemiol.6(4), 267–278 (1999).
   PubMedGoogle Scholar
• Segato T, Midena E, Grigoletto F et al. The epidemiology and prevalence of diabetic retinopathy in the Veneto region of north east Italy. Veneto Group for Diabetic Retinopathy. Diabet. Med.8 Spec. No., S11–S16 (1991).
   Web of Science ®Google Scholar
• Sjolie AK, Stephenson J, Aldington S et al. Retinopathy and vision loss in insulin-dependent diabetes in Europe. The EURODIAB IDDM Complications Study. Ophthalmology104(2), 252–260 (1997).
   PubMed Web of Science ®Google Scholar
• Verhoeven S, van Ballegooie E, Casparie AF. Impact of late complications in Type 2 diabetes in a Dutch population. Diabet. Med.8(5), 435–438 (1991).
   PubMed Web of Science ®Google Scholar
• Jaross N, Ryan P, Newland H. Prevalence of diabetic retinopathy in an Aboriginal Australian population: results from the Katherine Region Diabetic Retinopathy Study (KRDRS). Report no. 1. Clin. Experiment. Ophthalmol.31(1), 32–39 (2003).
   PubMed Web of Science ®Google Scholar
• McKay R, McCarty CA, Taylor HR. Diabetic retinopathy in Victoria, Australia: the Visual Impairment Project. Br. J. Ophthalmol.84(8), 865–870 (2000).
   PubMed Web of Science ®Google Scholar
• Mitchell P. Development and progression of diabetic eye disease in Newcastle (1977–1984): rates and risk factors. Aust. N. Z. J. Ophthalmol.13(1), 39–44 (1985).
   PubMedGoogle Scholar
• Mitchell P, Smith W, Wang JJ, Attebo K. Prevalence of diabetic retinopathy in an older community. The Blue Mountains Eye Study. Ophthalmology105(3), 406–411 (1998).
   PubMed Web of Science ®Google Scholar
• Tapp RJ, Shaw JE, Harper CA et al. The prevalence of and factors associated with diabetic retinopathy in the Australian population. Diabetes Care26(6), 1731–1737 (2003).
   PubMed Web of Science ®Google Scholar
• Choremis J, Chow DR. Use of telemedicine in screening for diabetic retinopathy. Can. J. Ophthalmol.38(7), 575–579 (2003).
   PubMed Web of Science ®Google Scholar
• Hanley AJ, Harris SB, Mamakeesick M et al. Complications of Type 2 Diabetes Among Aboriginal Canadians: prevalence and associated risk factors. Diabetes Care28(8), 2054–2057 (2005).
   PubMed Web of Science ®Google Scholar
• Maberley D, Cruess AF, Barile G, Slakter J. Digital photographic screening for diabetic retinopathy in the James Bay Cree. Ophthalmic Epidemiol.9(3), 169–178 (2002).
   PubMed Web of Science ®Google Scholar
• Tennant MT, Greve MD, Rudnisky CJ, Hillson TR, Hinz BJ. Identification of diabetic retinopathy by stereoscopic digital imaging via teleophthalmology: a comparison to slide film. Can. J. Ophthalmol.36(4), 187–196 (2001).
   PubMed Web of Science ®Google Scholar
• Tennant MT, Rudnisky CJ, Hinz BJ, MacDonald IM, Greve MD. Tele-ophthalmology via stereoscopic digital imaging: a pilot project. Diabetes Technol. Ther.2(4), 583–587 (2000).
   PubMedGoogle Scholar
• Sparrow JM, McLeod BK, Smith TD, Birch MK, Rosenthal AR. The prevalence of diabetic retinopathy and maculopathy and their risk factors in the non-insulin-treated diabetic patients of an English town. Eye7(Pt 1), 158–163 (1993).
   PubMed Web of Science ®Google Scholar
• Arfken CL, Salicrup AE, Meuer SM et al. Retinopathy in African Americans and whites with insulin-dependent diabetes mellitus. Arch. Intern. Med.154(22), 2597–2602 (1994).
   PubMedGoogle Scholar
• Dwyer MS, Melton LJ 3rd, Ballard DJ, Palumbo PJ, Trautmann JC, Chu CP. Incidence of diabetic retinopathy and blindness: a population-based study in Rochester, Minnesota. Diabetes Care8(4), 316–322 (1985).
   PubMed Web of Science ®Google Scholar
• Estacio RO, McFarling E, Biggerstaff S, Jeffers BW, Johnson D, Schrier RW. Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. Am. J. Kidney Dis.31(6), 947–953 (1998).
   PubMed Web of Science ®Google Scholar
• Klein BE, Davis MD, Segal P et al. Diabetic retinopathy. Assessment of severity and progression. Ophthalmology91(1), 10–17 (1984).
   PubMed Web of Science ®Google Scholar
• Klein R, Moss SE, Klein BE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. XI. The incidence of macular edema. Ophthalmology96(10), 1501–1510 (1989).
   PubMed Web of Science ®Google Scholar
• Lee ET, Lee VS, Kingsley RM et al. Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factors. Diabetes Care15(11), 1620–1627 (1992).
   PubMed Web of Science ®Google Scholar
• Nelson RG, Wolfe JA, Horton MB, Pettitt DJ, Bennett PH, Knowler WC. Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians. Diabetes38(4), 435–440 (1989).
   PubMed Web of Science ®Google Scholar
• Tudor SM, Hamman RF, Baron A, Johnson DW, Shetterly SM. Incidence and progression of diabetic retinopathy in Hispanics and non-Hispanic whites with Type 2 diabetes. San Luis Valley Diabetes Study, Colorado. Diabetes Care21(1), 53–61 (1998).
   PubMed Web of Science ®Google Scholar
• Agardh CD, Agardh E, Torffvit O. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in Type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care. Diabetes Res. Clin. Pract.35(2–3), 113–121 (1997).
   PubMed Web of Science ®Google Scholar
• Agardh E, Agardh CD, Koul S, Torffvit O. A four-year follow-up study on the incidence of diabetic retinopathy in older onset diabetes mellitus. Diabet. Med.11(3), 273–278 (1994).
   PubMed Web of Science ®Google Scholar
• Guillausseau PJ, Massin P, Charles MA et al. Glycaemic control and development of retinopathy in Type 2 diabetes mellitus: a longitudinal study. Diabet. Med.15(2), 151–155 (1998).
   PubMed Web of Science ®Google Scholar
• Nielsen NV. Diabetic retinopathy I. The course of retinopathy in insulin-treated diabetics. A one year epidemiological cohort study of diabetes mellitus. The Island of Falster, Denmark. Acta Ophthalmol. (Copenh.)62(2), 256–265 (1984).
   Google Scholar
• Rossing K, Jacobsen P, Rossing P, Lauritzen E, Lund-Andersen H, Parving HH. Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy. Diabetes Care21(11), 2007–2015 (1998).
   PubMed Web of Science ®Google Scholar
• Cohen DL, Neil HA, Thorogood M, Mann JI. A population-based study of the incidence of complications associated with Type 2 diabetes in the elderly. Diabet. Med.8(10), 928–933 (1991).
   PubMed Web of Science ®Google Scholar
• Jaross N, Ryan P, Newland H. Incidence and progression of diabetic retinopathy in an Aboriginal Australian population: results from the Katherine Region Diabetic Retinopathy Study (KRDRS). Report no. 2. Clin. Experiment. Ophthalmol.33(1), 26–33 (2005).
   PubMed Web of Science ®Google Scholar
• McCarty DJ, Fu CL, Harper CA, Taylor HR, McCarty CA. Five-year incidence of diabetic retinopathy in the Melbourne Visual Impairment Project. Clin. Experiment. Ophthalmol.31(5), 397–402 (2003).
   PubMed Web of Science ®Google Scholar
• Mitchell P, Moffitt P. Update and implications from the Newcastle diabetic retinopathy study. Aust. N. Z. J. Ophthalmol.18(1), 13–17 (1990).
   PubMedGoogle Scholar
• Chaturvedi N, Sjoelie AK, Porta M et al. Markers of insulin resistance are strong risk factors for retinopathy incidence in Type 1 diabetes. Diabetes Care24(2), 284–289 (2001).
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. The incidence of vision loss in a diabetic population. Ophthalmology95(10), 1340–1348 (1988).
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. Ten-year incidence of visual loss in a diabetic population. Ophthalmology101(6), 1061–1070 (1994).
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. The 14-year incidence of visual loss in a diabetic population. Ophthalmology105(6), 998–1003 (1998).
   PubMed Web of Science ®Google Scholar
• Henricsson M, Tyrberg M, Heijl A, Janzon L. Incidence of blindness and visual impairment in diabetic patients participating in an ophthalmological control and screening programme. Acta Ophthalmol. Scand.74(6), 533–538 (1996).
   PubMedGoogle Scholar
• Jeppesen P, Bek T. The occurrence and causes of registered blindness in diabetes patients in Arhus County, Denmark. Acta Ophthalmol. Scand.82(5), 526–530 (2004).
   PubMedGoogle Scholar
• Lovestam-Adrian M, Agardh CD, Torffvit O, Agardh E. Diabetic retinopathy, visual acuity, and medical risk indicators: a continuous 10-year follow-up study in Type 1 diabetic patients under routine care. J. Diabetes Complicat.15(6), 287–294 (2001).
   PubMed Web of Science ®Google Scholar
• Voutilainen-Kaunisto R, Terasvirta M, Uusitupa M, Niskanen L. Maculopathy and visual acuity in newly diagnosed Type 2 diabetic patients and non-diabetic subjects: a 10-year follow-up study. Acta Ophthalmol. Scand.79(2), 163–168 (2001).
   PubMedGoogle Scholar
• Voutilainen-Kaunisto RM, Terasvirta ME, Uusitupa MI, Niskanen LK. Occurrence and predictors of retinopathy and visual acuity in Type 2 diabetic patients and control subjects. 10-year follow-up from the diagnosis. J. Diabetes Complicat.15(1), 24–33 (2001).
   PubMed Web of Science ®Google Scholar
• Arun CS, Ngugi N, Lovelock L, Taylor R. Effectiveness of screening in preventing blindness due to diabetic retinopathy. Diabet. Med.20(3), 186–190 (2003).
   PubMed Web of Science ®Google Scholar
• Cormack TG, Grant B, Macdonald MJ, Steel J, Campbell IW. Incidence of blindness due to diabetic eye disease in Fife 1990–1999. Br. J. Ophthalmol.85(3), 354–356 (2001).
   PubMed Web of Science ®Google Scholar
• Prasad S, Kamath GG, Jones K, Clearkin LG, Phillips RP. Prevalence of blindness and visual impairment in a population of people with diabetes. Eye15(Pt 5), 640–643 (2001).
   PubMed Web of Science ®Google Scholar
• McKay R, McCarty CA, Taylor HR. Diabetes in Victoria, Australia: the Visual Impairment Project. Aust. NZ J. Public Health24(6), 565–569 (2000).
   PubMed Web of Science ®Google Scholar